Should we STOP immunosuppression for IgA nephropathy? Long-term outcomes from the STOP-IgAN trial

被引：5
|
作者：
Cheung, Chee Kay [1 ,2 ]
Barratt, Jonathan [1 ,2 ]
机构：
[1] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England
[2] Univ Hosp Leicester NHS Trust, John Walls Renal Unit, Leicester, Leics, England
来源：
KIDNEY INTERNATIONAL | 2020年 / 98卷 / 04期
关键词：
D O I：
10.1016/j.kint.2020.05.033
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
The role of immunosuppression in the management of IgA nephropathy remains highly controversial. The Supportive Versus Immunosuppressive Therapy for the Treatment of Progressive IgA Nephropathy (STOP-IgAN) trial suggested that there was no benefit with the addition of immunosuppression to intensive supportive care, in terms of renal outcome. In this edition of Kidney International, Rauen et al. report long-term outcomes from the STOP-IgAN trial. Crown Copyright (C) 2020, Published by Elsevier, Inc., on behalf of the International Society of Nephrology. All rights reserved.
引用
收藏
页码：836 / 838
页数：4
相关论文
共 50 条
  • [21] Long-term trial of steroid and angiotensin receptor blocker in IgA nephropathy
    Ihm, Chun-Gyoo
    Lee, T.
    Lee, S.
    Jeong, K.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 62 - 62
  • [22] Long-term outcomes of patients with IgA nephropathy in the German CKD cohort
    Stamellou, Eleni
    Nadal, Jennifer
    Hendry, Bruce
    Mercer, Alex
    Seikrit, Claudia
    Bechtel-walz, Wibke
    Schmid, Matthias
    Moeller, Marcus J.
    Schiffer, Mario
    Eckardt, Kai-uwe
    Kramann, Rafael
    Floege, Juergen
    CLINICAL KIDNEY JOURNAL, 2024, 17 (08)
  • [23] Stop being so superficial: subcortical disconnection and long-term seizure outcomes
    Inati, Sara K.
    Zaghloul, Kareem A.
    BRAIN, 2023, 146 (06) : 2203 - 2205
  • [24] Long-term effects of immunosuppression treatment on IgA nephropathy: a systematic review and meta-analysis
    Chen, Na
    Huang, Hao-Le
    Yang, Yan-Di
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (11) : 11830 - 11839
  • [25] Prognostic factors affecting long-term outcomes in patients with concurrent IgA nephropathy and membranous nephropathy
    Qin, Yunlong
    Yu, Zixian
    Wu, Hao
    Wang, Anjing
    Wang, Fang
    Wang, Di
    Jia, Qing
    Yuan, Jinguo
    Xing, Yan
    Zhang, Yumeng
    Zhao, Jin
    Sun, Shiren
    HELIYON, 2024, 10 (01)
  • [26] THE ASSOCIATION OF ENDOCAPILLARY HYPERCELLULARITY WITH LONG-TERM RENAL OUTCOMES IN CHINESE IGA NEPHROPATHY
    Li, J.
    Huang, N.
    Zhou, Q.
    Yang, S.
    Yu, J.
    Fu, D.
    Guo, L.
    Yang, Q.
    Yu, X.
    NEPHROLOGY, 2016, 21 : 134 - 134
  • [27] Corticosteroid effectiveness in IgA nephropathy: Long-term results of a randomized, controlled trial
    Pozzi, C
    Andrulli, S
    Del Vecchio, L
    Melis, P
    Fogazzi, GB
    Altieri, P
    Ponticelli, C
    Locatelli, F
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (01): : 157 - 163
  • [28] Long-term renal outcomes of IgA nephropathy presenting with different levels of proteinuria
    Ai, Zhen
    Zhou, Qian
    Huang, Fengxian
    Yang, Qiongqiong
    Yu, Xueqing
    CLINICAL NEPHROLOGY, 2020, 94 (06) : 290 - 296
  • [29] Can We StoP Worrying about Long-term PPIs and Gastric Cancer Risk?
    Richman, Courtney M.
    Leiman, David A.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2023, 32 (09) : 1127 - 1129
  • [30] Increased Serum IgA in Children with IgA Nephropathy, Severity of Kidney Biopsy Findings and Long-Term Outcomes
    Mizerska-Wasiak, M.
    Maldyk, J.
    Panczyk-Tomaszewska, M.
    Turczyn, A.
    Cichon-Kawa, K.
    Rybi-Szuminska, A.
    Wasilewska, A.
    Firszt-Adamczyk, A.
    Stankiewicz, R.
    Bienias, B.
    Zajaczkowska, M.
    Gadomska-Prokop, K.
    Grenda, R.
    Miklaszewska, M.
    Pietrzyk, J.
    Pukajlo-Marczyk
    Zwolinska, D.
    Szczepanska, M.
    Demkow, U.
    Roszkowska-Blaim, M.
    VENTILATORY DISORDERS, 2015, 873 : 79 - 86
12345